Recently, U.S. Food and Drug Administration and Centers for Disease Control and Prevention committees unanimously supported the Novavax COVID-19 vaccine. It is already used in Canada, South Korea, India, Australia, and the European Union.

The United States Emergency Use Authorization allows its use for the primary series as two-shots given three weeks apart to those 18 years and older.

Vaccine Smarts is written by Sealy Institute for Vaccine Sciences faculty members Drs. Megan Berman, an associate professor of internal medicine, and Richard Rupp, a professor of pediatrics at the University of Texas Medical Branch. For questions about vaccines, email vaccine.smarts@utmb.edu.

0
0
0
0
0

(0) comments

Welcome to the discussion.

Internet forum rules ...
Real names required. No pseudonyms or partial names allowed. Stand behind what you post.
Keep it clean. Don't use obscene, vulgar, lewd, racist or sexually oriented language.
Don't threaten. Threats of harming another person will not be tolerated.
Be truthful. Don’t knowingly lie about anyone or anything.
Be nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be brief. Keep posts to 250 words or less.
Edit yourself. No more than three posts per thread and stay on topic. Do not link to sites outside galvnews.com.
Be aware. All posts are property of The Daily News and may be republished in print.
Be proactive. Use the "Report" link on each comment to let us know of rule violations.

Thank you for reading!

Please log in, or sign up for a new account and purchase a subscription to read or post comments.